IL6 and cholangiocarcinoma: Participants with the most elevated level of plasma interleukin-6 were found to have an increased risk of 19 and 150 times of developing APF and CCA, respectively, as compared with other O. viverrini infected individuals with no detectable plasma interleukin-6 [49].